The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIntercede Regulatory News (IGP)

Share Price Information for Intercede (IGP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 105.50
Bid: 103.00
Ask: 108.00
Change: -0.50 (-0.47%)
Spread: 5.00 (4.854%)
Open: 105.50
High: 105.00
Low: 105.00
Prev. Close: 105.50
IGP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Launch of latest version of MyID PIV

15 Jul 2010 07:00

RNS Number : 3747P
Intercede Group PLC
15 July 2010
 



 

Intercede Group plc

("Intercede" or the "Company")

 

Intercede Announces the Most Comprehensive Software Platform for PIV, PIV-I and PIV-C Identity and Credential Management Projects

Highlights:

·; Latest version of MyID PIV now available - MyID PIV 8 SR1

·; Based on the most recent PIV Standards

·; Levers MyID's interoperability to exploit convergence between Federal and non-Federal identity and credential management projects

·; Proven Deployments

 

London, United Kingdom, 15 July 2010 - Intercede (London Stock Exchange AIM: IGP) today announced the release of MyID PIV Version 8 Service Release 1 (SR1) for US Federal, State and Local Government. This latest version of MyID PIV supports the most recent Federal Information Processing Standard 201 (FIPS 201) updates and is in use and available today.

Intercede already has more than 10 US Federal Government Agencies already using MyID PIV 8 and we anticipate that most of these customers will be contracting to upgrade to the new SR1 version over the coming months. The benefit to Agencies is that SR1 will enable them to maintain compliance with the recently modified SP800-73-3 standard as well as facilitating the use of the latest Microsoft platforms.

MyID PIV 8 SR1 also builds on Intercede's substantial experience in supporting non-Federal customers who need to issue identity credentials that are interoperable with the US Federal PIV systems (PIV-I). The programs include Transportation Worker Identity Credential (TWIC), First Responder Authentication Credential (FRAC) and Airport Credentials Interoperability Solution (ACIS). Intercede has already won the TWIC system, has secured a growing number of early FRAC deployments and anticipates participating in the ACIS program.

In addition, MyID PIV 8 SR1 supports private sector US government contractor organisations that wish to benefit from issuing credentials that are compatible with PIV compliant security hardware and electronic card content . These solutions are termed PIV compatible (PIV-C). Intercede is already supplying PIV-C solutions to Lockheed Martin (150,000 employees) and a major US government integrator/consultancy group in the DC area. Intercede anticipates deploying PIV-C to other major customers later this year.

MyID PIV was the first card management system to be listed on the FIPS 201 approved products list and is the only PIV identity and credential management platform that provides a single point for registration, identity checking/vetting, issuance, lifecycle management and auditing/reporting. Two of the key advantages which are unique to MyID PIV are a single point of revocation for PIV identity cards and other credentials (e.g. RSA SecureID tokens) and a single point of auditing and reporting across all stages (registration, identity checking/vetting and issuance) of the PIV card lifecycle. 

What's New in MyID 8 PIV SR1

·; Support for PIV-I and PIV-C

·; Support for the latest standards for PIV, PIV-I and PIV-C (SP800-73-3)

·; Automatic on-card recovery of up to 20 historical encryption certificates

·; Support for the next generation PIV Cards including Oberthur, Gemalto, G&D and SafeNet

·; Usability Enhancements for PIV, PIV-I and PIV-C

·; Extended Microsoft Platform Support

Intercede President and Chief Executive, Richard Parris said, "This latest update to the MyID software platform continues Intercede's momentum as the premium supplier of PIV management systems to the US government and related markets. While our competitors have been talking about their aspirations in these sectors, Intercede has been steadily securing market share by delivering quality products and services that enable our customers to meet their program plans. As the next wave of PIV procurements commences, both inside and outside of government, Intercede is well positioned to extend existing deployments and to win business from new federal, state and private customers".

About Intercede

Intercede is the producer of the MyID® Identity and Credential Management System (IDCMS). Intercede's MyID is the only IDCMS software product that enables organizations to easily and securely manage the identities of people and their associated identity credentials within a single, integrated, workflow driven platform. This includes enabling and managing: secure registration, biometric capture, application vetting and approval through to smart card personalisation, issuance and management.

Intercede's MyID is being used around the world by large corporations, governments and banks to manage millions of identities for employees, citizens and customers. Notable deployments in the US include more than 10 Federal Agencies, a program with Lockheed Martin and two major US financial institutions. In Europe and the Middle East, Intercede's MyID is being deployed in support of government identity, health and corporate employee ID security projects.

For more information visit www.intercede.com

###

ENQUIRIES

Intercede Group plc Richard Parris, Chairman & Chief Executive Andrew Walker, Finance Director Tel. +44 (0)1455 558111

finnCap Clive Carver, Corporate Finance Joanna Weaving, Corporate Broking Tel. +44 (0)20 7600 1768

Pelham Bell Pottinger, Public Relations Archie Berens/Francesca Tuckett Tel. +44 (0)20 7861 3112

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRADZLFFBDFFBBZ
Date   Source Headline
26th Apr 202410:02 amRNSShare Incentive Scheme
23rd Apr 20247:00 amRNSCapital Markets Day
8th Apr 20247:00 amRNSTrading Update
2nd Apr 20247:00 amRNSContract and Subscription Renewals
25th Mar 20243:38 pmRNSHolding(s) in Company
25th Mar 20243:35 pmRNSHolding(s) in Company
22nd Mar 20247:00 amRNSNew Orders and Trading Update
21st Mar 20247:00 amRNSNew Product Announcement: Launch of MyID MFA v5
6th Feb 20247:00 amRNSDirector/PDMR Shareholding
29th Jan 20247:00 amRNSNew Orders
18th Jan 20249:55 amRNSDirector/PDMR Shareholding
3rd Jan 20247:00 amRNSMajor New Contract Win
7th Dec 20237:00 amRNSUpdate on Major New Contract Win
5th Dec 202312:30 pmRNSMajor New Contract with Large US Federal Agency
22nd Nov 20237:00 amRNSDirector/PDMR Shareholding
21st Nov 20237:01 amRNSNew Contract and Renewal Orders
21st Nov 20237:00 amRNSHalf-year Report
7th Nov 20237:00 amRNSContract and Renewals Orders
25th Oct 20234:44 pmRNSDirector/PDMR Shareholding
24th Oct 20237:00 amRNSNotice of Interim Results & Investor Presentation
20th Oct 20237:03 amRNSAppointment of Non-Executive Director
11th Oct 20237:00 amRNSDirector/PDMR Shareholding
10th Oct 20237:00 amRNSTrading Update
21st Sep 20231:31 pmRNSResult of AGM
4th Sep 20237:00 amRNSContract and Renewals Orders
30th Aug 20237:10 amRNSNotice of AGM and Publication of Annual Report
20th Jun 20237:01 amRNSBoard Changes
20th Jun 20237:00 amRNSFinal Results
12th Jun 20237:00 amRNSNotice of Results & Investor Presentation
27th Apr 20237:00 amRNSShare Incentive Plan
17th Apr 20237:00 amRNSTrading Update
3rd Apr 20237:00 amRNSContract wins/renewals
3rd Feb 202310:46 amRNSDirector/PDMR Shareholding
31st Jan 20237:00 amRNSChange of Auditors
23rd Jan 20234:40 pmRNSSecond Price Monitoring Extn
23rd Jan 20234:35 pmRNSPrice Monitoring Extension
23rd Jan 20232:05 pmRNSSecond Price Monitoring Extn
23rd Jan 20232:00 pmRNSPrice Monitoring Extension
23rd Jan 20237:00 amRNSTrading Update
11th Jan 20232:30 pmRNSDirector/PDMR Shareholding
2nd Dec 20228:45 amRNSDirector/PDMR Shareholding
22nd Nov 20227:00 amRNSHalf-year Report
11th Nov 20227:00 amRNSNotice of Interim Results & Investor Presentation
13th Oct 202210:30 amRNSDirector/PDMR Shareholding
11th Oct 20221:00 pmRNSDirector/PDMR Shareholding
10th Oct 20228:00 amRNSLong Term Incentive Plan
10th Oct 20227:01 amRNSAcquisition of Authlogics Ltd
10th Oct 20227:00 amRNSTrading Update
28th Sep 202212:22 pmRNSResult of AGM
15th Sep 20227:00 amRNSDirector/PDMR Shareholding and Issue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.